Therapeutic Potential of CRISPR–Cas3 Genome-Editing System for Transthyretin Amyloidosis. Credit: Institute of Medical ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

Anthropic CEO Dario Amodei on Monday laid out the startup’s vision for how AI could solve problems in healthcare and the life sciences, from speeding up drug approvals by streamlining clinical trial ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...

Baby KJ was the first to receive a bespoke gene-editing treatment. Personalized drugs for others could be approved within the ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Scientists have used CRISPR to give the goldenberry a modern makeover, shrinking the plant by about a third and making it ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...